Mateo Forero

Experience

• 

  BBVA en Colombia

  Aug 2019 - Feb 2021

  Asesor integral de servicios

  • Financial products sales: Loans, credit cards and insurances. • Commercial management for main company customers• Execute process such as deposits, withdrawals, tax payments and correspondence reception.

• 

  Astellas Pharma

  Feb 2021 - Apr 2023

  • Oversee business distributors’ markets for Latin America, being 40% of total sales for the region. Budget achievement of +105% and 11% growth vs previous year. • Prioritize commercial development of main oncology and urology therapies, considering market barriers for its reimbursement and/or use. Led commercial transition to another distributor, improving company net margin and operational profit. • Plan footprint deployment of the region through flawless execution of new therapies launch across the region, guaranteeing company development and self-sustaining in the short, mid, and long term.• Commercial management of new relationships, represented in upsides sales and no extra investment. Show less • Customize commercial strategy execution according to product lifecycle management and market dynamics. • Build key relationships with external stakeholders and decision makers, being part of Astellas Pharma Mexico opening, represented in 5-years term the biggest affiliate in sales term. • Enhance of process and budget within hub relocation from US to Colombia, with a streamline of resources and scope. • Create sales dashboards to understand business current state, per geography and product, anticipating to gaps and identifying opportunities across the markets. Show less

  • Latam Partner Management Associate

    Jul 2022 - Apr 2023

  • Partner Management Analyst

    Aug 2021 - Jul 2022

  • Administrative Trainee Latam Area

    Feb 2021 - Aug 2021
• 

  AbbVie

  May 2023 - now

  Innovative Access Models Coordinator

  • Lead commercial agreements area to address payors’ needs, linked with commercial strategy per product and account.• Develop avant-garde commercial models, which allows innovative therapies uptake, looking for decision maker desire outcome and assurance a healthy P&L.• Rethink commercial policy to improve assets' market position in multiple therapeutic areas (oncology, inmunology, neuroscience, ophthalmology, specialty care), increasing net margin for the company.